Keywords: USA, Health rform, Senate, GPhA, Biologicals, Biogenerics

US generic drugmakers say Senate HCR Bill “gratuitously extends biologic monopolies”

Article | 20 November 2009

Adding its comments on the US Senate Health Care Reform proposal introduced a day earlier (The Pharma Letter November 19), Generic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in